cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG [Genvoya]
RxNorm concept 1721615, branded drug component (sbdc).
- RxCUI
- 1721615
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721615 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Genvoya] (SBD, constitutes)
- Genvoya (BN, has ingredient)
- emtricitabine 200 MG (SCDC, tradename of)
- cobicistat 150 MG (SCDC, tradename of)
- elvitegravir 150 MG (SCDC, tradename of)
- tenofovir alafenamide 10 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1721615 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1721615 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1721615. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.